N
Novavax, Inc.
NVAX · NASDAQ · Healthcare · 1.3B
Closing price
$12.75
+15.80% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
4.7×
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
4.2×
Free cash flow yieldFCF yield
-12.1%
Return on equityROE
-344.7%
Operating margin
50.1%
Net debt / EBITDAbalance-sheet strength
0.0×
Interest coverage
25.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.